• Skip to primary navigation
  • Skip to main content
PaLaDIn logo

Project PaLaDIn

  • What is PaLaDIn?
    • What will PaLaDIn do?
    • FAQ
  • Partners
    • Meet the Team
  • Resources
  • News
    • Newsletters
    • Publications
    • Press
    • Published Deliverables
  • Engagement
  • Contact us
  • eu-paladin
  • YouTube

Maximising the Interactium® Benefits: Invitation to Tender

29 September 2025 by PaLaDIn Comms

Within PaLaDIn, partners will work together to identify ways to maximise the benefits of the PaLaDIn Interactium® data platform, using FSHD as a case study. To support this work, PaLaDIn Scientific Coordinator TREAT-NMD seeks a provider (or consortium of providers) to provide skills and expertise, with a specific focus on generating a Health Technology Assessment (HTA) disease-model, developing a model patient journey of FSHD, and evaluating the effectiveness of patient support programs already in place.

The successful provider will bring experience in HTA evidence generation in the rare, genetic, neuromuscular diseases space, with a particular emphasis on FSHD. Ideally, the provider will have experience of working alongside patient advocacy and other organisations in the European FSHD community. To read the full tender and to find out more information about applying, click here.

Filed Under: News

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132943. The JU receives support from the European Union’s Horizon Europe research and innovation programme, COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe (and the FSHD Society and TREAT-NMD Services Ltd as contributing partners participating in the project). The project will also receive funding from UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant numbers 10105921, 10103989, and 10083579]

ALL funder logos PaLaDIn
Privacy Policy Sitemap ©PROJECT PALADIN 2026